MERCK & CO., INC. (MRK)
Clinical trial NCT04123366 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-29 → 2026-06-08 3. primary completion date: 2026-06-29 → 2026-06-08 4. enrollment: 300 → 333 participants 5. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (62%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical